Yahya Muhieddine Portfolio

Invests via Eleva Capital SAS | Managed by Yahya Muhieddine

Invests via Eleva Capital SAS

Managed by Yahya Muhieddine

Automatically Tracked

Tracking: 0 Updated: Yesterday at 02:45 PM

Seasoned operator and investor focused on technology and financial services, Yahya Muhieddine combines multi-market operating experience with active angel and seed-stage investing. He has led startups through product-market fit and capital raises, advised growth-stage management teams, and participates in early-stage syndicates targeting fintech, SaaS and marketplaces across MENA and Europe. Market-facing strengths include capital formation, go-to-market strategy and corporate partnerships.

Investment Philosophy & Strategy

Combines operator-led, thesis-driven early-stage investing with active portfolio support in fintech, SaaS and marketplace models across MENA and Europe. Focuses on seed and pre-seed opportunities where founder-market fit and scalable go-to-market motion are evident, deploying concentrated capital with reserved follow-on allocation. Investment decisions favor durable unit economics, partnership-driven distribution channels and defensible product propositions. Emphasizes rapid validation, capital formation expertise and board/advisor involvement to accelerate growth toward strategic exits or growth rounds.

Disclaimer: This Portfolio is derived from and computed based on publicly available data from SEC filings.

Gain and growth charts are calculated per selected timeframe:

1.05%

Gain

Monthly

0.08%

Yearly

Drawdown

19.12%

$341.41M

Equity

Holdings

$341.41M

Investment

$308.73M

$37.51M

Profit -$3.89M

Realized

$4.83M

Unrealized

$32.68M

Dividends

$4.47M

Goals

Avg. 40.5% completed goals

Yearly

Gain > 5%

2026

Yearly

Gain < 20%

2026

81%

Today

Compared To Yesterday

Gain

Profit

-$3.89M

Win %

58%

This Week

Compared To Last Week

Gain

-0.59%

Profit

-$2.03M

Win %

58%

This Month

Compared to last month

Gain

-2.99%

Profit

-$10.52M

Win %

58%

This Year

Compared to last year

Gain

-3.88%

Profit

-$15.23M

Win %

64%

Gainers
Losers

CGON CG Oncology, Inc.

+4.59%

+$26,427.82

EWTX Edgewise Therapeutics, Inc.

+3.87%

+$25,840.8

IRON Disc Medicine Inc.

+3.63%

+$13,657.05

FENC Fennec Pharmaceuticals Inc.

+3.06%

+$17,034.88

NAMS NewAmsterdam Pharma Co. N.V.

+2.59%

+$20,702.83

AQST Aquestive Therapeutics Inc.

+2.28%

+$244.8

MLYS Mineralys Therapeutics, Inc.

+1.81%

+$8,369.69

TMUS T-Mobile US, Inc.

+1.33%

+$36,764.19

VRDN Viridian Therapeutics Inc.

+0.3%

+$381.24

ESPR Esperion Therapeutics Inc.

H5919C104

TSMWF Taiwan Semiconductor Manufacturing Company Limited

NFLX Netflix, Inc.

-8.73%

-$565,863.1

HOOD Robinhood Markets, Inc.

-4.89%

-$163,817.5

ACHR Archer Aviation Inc.

-2.34%

-$2,261.07

GOOGL Alphabet Inc

-2.1%

-$207,794.81

NVDA NVIDIA Corporation

-2.01%

-$216,328.32

SPOT Spotify Technology S.A.

-1.84%

-$23,851.25

ANET Arista Networks, Inc.

-1.8%

-$142,279.71

BSX Boston Scientific Corporation

-1.23%

-$14,666.85

AS Amer Sports, Inc.

-1%

-$107,568.72

CRH CRH plc

-0.92%

-$2.59M

FCX Freeport-McMoRan Inc.

-0.58%

-$767.72

AMZN Amazon.com Inc

-0.1%

-$4,200.3

Events

Dividends

Dividend Analysis

No Data

Trades 70	Longs Won 24/70 34%	Profit Factor 6.4
Profitability	Shorts Won 0/0 0%	Standard Deviation $3.87M
Average Win $1.85M	Best Trade (Jul 17) $32.02M	Sharpe Ratio -63.05
Average Loss -$150,981.51	Worst Trade (Jul 10) -$2.65M	Z-Score -2.15 (100%)
Commissions $0	Avg. Trade Length 5m	Expectancy $535,916

Loss Size	100%	90%	80%	70%	60%	50%	40%	30%	20%	10%
Probability of Loss	<0.01%	<0.01%	<0.01%	<0.01%	<0.01%	<0.01%	<0.01%	0.02%	0.44%	7.73%
Consecutive Losing Trades	2,262	2,036	1,810	1,584	1,357	1,131	905	679	452	226